| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.3 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.3 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.058 | 0.3 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.3 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.3 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.086 | 0.3 |